Matches in SemOpenAlex for { <https://semopenalex.org/work/W4229448906> ?p ?o ?g. }
- W4229448906 endingPage "113066" @default.
- W4229448906 startingPage "113066" @default.
- W4229448906 abstract "The ATP-adenosine pathway functions as a key modulator of innate and adaptive immunity within the tumor microenvironment, and cancer immune evasion largely involves the generation of high amounts of immunosuppressive extracellular adenosine (eADO). Consequently, inhibition of eADO-generating enzymes and/or eADO receptors can effectively restore the antitumor immunity of multiple immune cells. With several clinical strategies currently being explored to modulating the eADO pathway in patients with cancer, recent clinical data with antagonists targeting CD73 and A2A receptor have demonstrated a promising therapeutic potential in cancer. Recent findings reveal that the ectonucleotidase CD39, the limiting enzyme been viewed as immunological switch, converts ATP-driven pro-inflammatory milieu to an anti-inflammatory state mediated by adenosine. Owing to its superior feature of CD39 antagonism that rely not only on preventing the accumulation of adenosine but also on the stabilization of extracellular ATP to restore antitumor immunity, several inhibitors and clinical trials based on CD39 are being evaluated. Consequently, there is currently a focus on understanding the role of CD39 in governing immunity and how therapeutic strategies targeting this pathway alter the antitumor potential. We herein review the impact of CD39 on tumor microenvironment with a focus on treatment preference. Additionally, we also discuss the implication for rational combination therapies, molecular regulation, as well as potential limitations." @default.
- W4229448906 created "2022-05-11" @default.
- W4229448906 creator A5023636658 @default.
- W4229448906 creator A5036036670 @default.
- W4229448906 creator A5071155669 @default.
- W4229448906 date "2022-07-01" @default.
- W4229448906 modified "2023-10-09" @default.
- W4229448906 title "CD39 – A bright target for cancer immunotherapy" @default.
- W4229448906 cites W1235696336 @default.
- W4229448906 cites W1492226152 @default.
- W4229448906 cites W1501783126 @default.
- W4229448906 cites W1506816544 @default.
- W4229448906 cites W1518501806 @default.
- W4229448906 cites W1565285014 @default.
- W4229448906 cites W1873838517 @default.
- W4229448906 cites W1906804363 @default.
- W4229448906 cites W1918855189 @default.
- W4229448906 cites W1940131053 @default.
- W4229448906 cites W1963492398 @default.
- W4229448906 cites W1965316405 @default.
- W4229448906 cites W1965782067 @default.
- W4229448906 cites W1966919402 @default.
- W4229448906 cites W1969645166 @default.
- W4229448906 cites W1971339571 @default.
- W4229448906 cites W1974059338 @default.
- W4229448906 cites W1977187462 @default.
- W4229448906 cites W1982488143 @default.
- W4229448906 cites W1987062630 @default.
- W4229448906 cites W1990113288 @default.
- W4229448906 cites W1993334366 @default.
- W4229448906 cites W1999998145 @default.
- W4229448906 cites W2001312442 @default.
- W4229448906 cites W2005542488 @default.
- W4229448906 cites W2005628887 @default.
- W4229448906 cites W2016786549 @default.
- W4229448906 cites W2023811960 @default.
- W4229448906 cites W2029733235 @default.
- W4229448906 cites W2030272844 @default.
- W4229448906 cites W2036759701 @default.
- W4229448906 cites W2038994844 @default.
- W4229448906 cites W2043291701 @default.
- W4229448906 cites W2049601932 @default.
- W4229448906 cites W2050688486 @default.
- W4229448906 cites W2054661897 @default.
- W4229448906 cites W2059124020 @default.
- W4229448906 cites W2059476255 @default.
- W4229448906 cites W2067223216 @default.
- W4229448906 cites W2077703512 @default.
- W4229448906 cites W2077930885 @default.
- W4229448906 cites W2078254195 @default.
- W4229448906 cites W2078544167 @default.
- W4229448906 cites W2082083390 @default.
- W4229448906 cites W2083751011 @default.
- W4229448906 cites W2085596919 @default.
- W4229448906 cites W2086335229 @default.
- W4229448906 cites W2097478351 @default.
- W4229448906 cites W2097995306 @default.
- W4229448906 cites W2101590536 @default.
- W4229448906 cites W2101653483 @default.
- W4229448906 cites W2108280177 @default.
- W4229448906 cites W2113661022 @default.
- W4229448906 cites W2121269733 @default.
- W4229448906 cites W2121815506 @default.
- W4229448906 cites W2131878959 @default.
- W4229448906 cites W2137174179 @default.
- W4229448906 cites W2141035582 @default.
- W4229448906 cites W2146110549 @default.
- W4229448906 cites W2153092839 @default.
- W4229448906 cites W2158862722 @default.
- W4229448906 cites W2160141570 @default.
- W4229448906 cites W2162883643 @default.
- W4229448906 cites W2294221492 @default.
- W4229448906 cites W2396395844 @default.
- W4229448906 cites W2403293254 @default.
- W4229448906 cites W2469758901 @default.
- W4229448906 cites W2474535137 @default.
- W4229448906 cites W2519184848 @default.
- W4229448906 cites W2591655768 @default.
- W4229448906 cites W2605835842 @default.
- W4229448906 cites W2680456958 @default.
- W4229448906 cites W2692164552 @default.
- W4229448906 cites W2744149134 @default.
- W4229448906 cites W2757710931 @default.
- W4229448906 cites W2766745368 @default.
- W4229448906 cites W2769926755 @default.
- W4229448906 cites W2773431528 @default.
- W4229448906 cites W2774533844 @default.
- W4229448906 cites W2775177930 @default.
- W4229448906 cites W2779221466 @default.
- W4229448906 cites W2804340288 @default.
- W4229448906 cites W2808790891 @default.
- W4229448906 cites W2849303123 @default.
- W4229448906 cites W2883867232 @default.
- W4229448906 cites W2884332748 @default.
- W4229448906 cites W2885609962 @default.
- W4229448906 cites W2888235779 @default.
- W4229448906 cites W2890164569 @default.
- W4229448906 cites W2890795012 @default.